Barclays’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,817
Closed -$21.3K 5213
2023
Q3
$21.3K Buy
+1,817
New +$35.7K ﹤0.01% 4165
2022
Q4
Sell
-55
Closed -$5K 5258
2022
Q3
$5K Buy
+55
New +$4.9K ﹤0.01% 4488
2022
Q2
Sell
-769
Closed -$54K 4988
2022
Q1
$54K Buy
+769
New +$87.1K ﹤0.01% 4087
2021
Q1
Sell
-2,533
Closed -$1.14M 4641
2020
Q4
$1.14M Sell
2,533
-800
-24% -$277K ﹤0.01% 2664
2020
Q3
$1.03M Buy
+3,333
New +$1.03M ﹤0.01% 2662

Other funds holding ADN

Barclays's ADN Position: Q4 2023 in Review

Barclays sold out of Advent Technologies (ADN) in Q4 2023, closing a stake of 1,817 shares — an estimated $21.3K sold.

Barclays first reported a position in ADN in Q3 2020 and held it in 5 quarters. The position peaked at $1.14M in Q4 2020. 31 funds tracked by Wall St. Rank hold ADN as of Q4 2023.

  • Barclays reported no remaining Advent Technologies position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 1,817 Advent Technologies shares in Q4 2023, an estimated $21.3K.
  • Barclays first reported a position in Advent Technologies in Q3 2020 and held it in 5 quarters.
  • Barclays's Advent Technologies position peaked at $1.14M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Advent Technologies as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.